表紙:エピネフリン自動注射器の世界市場:投与量別、エンドユーザー別、地域別の市場調査、予測(~2026年)、COVID-19の累積的な影響
市場調査レポート
商品コード
1027181

エピネフリン自動注射器の世界市場:投与量別、エンドユーザー別、地域別の市場調査、予測(~2026年)、COVID-19の累積的な影響

Epinephrine Auto-Injector Market Research Report by Dosage, by End-User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 180 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.41円
エピネフリン自動注射器の世界市場:投与量別、エンドユーザー別、地域別の市場調査、予測(~2026年)、COVID-19の累積的な影響
出版日: 2021年09月07日
発行: 360iResearch LLP
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

エピネフリン自動注射器の市場規模は、2020年に2億6,802万米ドル、2021年に2億9,268万米ドルとなり、年平均成長率(CAGR)9.53%で成長し、2026年までに4億6,298万米ドルとなると予想されています。

当レポートではエピネフリン自動注射器の世界市場を調査し、市場の概要、市場の成長要因および阻害要因の分析、市場機会、COVID-19の影響、投与量・エンドユーザー・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーションとカバレッジ
  • 調査のために考慮された年
  • 通貨と価格
  • 言語
  • 制限事項
  • 仮定
  • 利害関係者

第2章 調査手法

  • 定義:調査目的
  • 決定:調査デザイン
  • 準備:調査機器
  • 収集:データソース
  • 分析:データの解釈
  • 策定:データ検証
  • 公開:調査レポート
  • 繰り返し:レポートの更新

第3章 エグゼクティブサマリー

  • 市場の見通し
  • 投与量の見通し
  • エンドユーザーの見通し
  • 地域の見通し
  • 競合他社の見通し

第4章 市場概要

  • COVID-19の累積的影響

第5章 市場の洞察

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • ポーターズのファイブフォース分析
    • 新規参入業者の脅威
    • 代替品の脅威
    • 顧客の交渉力
    • 供給企業の交渉力
    • 業界の競争

第6章 投与量別

  • 0.3Mg
  • 0.5Mg

第7章 エンドユーザー別

  • 診療所
  • 病院
  • 個人

第8章 南北アメリカ

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • タイ

第10章 欧州、中東・アフリカ

  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品の満足度
  • 市場ランキング分析
  • キープレーヤー別市場シェア分析
  • 競合シナリオ
    • 合併と買収
    • 契約、コラボレーション、およびパートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 賞、表彰、拡大

第12章 企業のユーザビリティプロファイル

  • ALK-Abello A/S
  • Amedra Pharmaceuticals LLC
  • Amgen Inc.
  • Amneal Pharmaceuticals Inc.
  • Antares Pharma Inc.
  • Bausch Health Companies, Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • BPI Labs, Inc.
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Hospice Inc
  • Hospira Inc.
  • Impax Laboratories, Inc.
  • Janssen Global Services, LLC
  • Kaleo, Inc.
  • Lincoln Medical Centre Ltd.
  • Lincoln Medical Ltd
  • Merck KGaA
  • Mylan Inc
  • Novartis International AG
  • Pfizer, Inc.
  • Sanofi SA
  • Teva Pharmaceuticals Lts
  • Ypsomed Holding

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格
図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY REGION, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 6. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET: MARKET DYNAMICS
  • FIGURE 7. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 8. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2020 VS 2026 (%)
  • FIGURE 9. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2020 VS 2026 (USD MILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2026
  • FIGURE 11. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY 0.3 MG EPINEPHRINE AUTOINJECTOR, 2018-2026 (USD MILLION)
  • FIGURE 12. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY 0.3 MG EPINEPHRINE AUTOINJECTOR, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 13. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY 0.5 MG EPINEPHRINE AUTOINJECTOR, 2018-2026 (USD MILLION)
  • FIGURE 14. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY 0.5 MG EPINEPHRINE AUTOINJECTOR, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY MG EPINEPHRINE AUTOINJECTOR, 2018-2026 (USD MILLION)
  • FIGURE 16. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY MG EPINEPHRINE AUTOINJECTOR, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 17. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
  • FIGURE 18. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2026
  • FIGURE 20. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY CLINICS, 2018-2026 (USD MILLION)
  • FIGURE 21. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY CLINICS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY HOSPITAL, 2018-2026 (USD MILLION)
  • FIGURE 23. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY HOSPITAL, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY INDIVIDUAL, 2018-2026 (USD MILLION)
  • FIGURE 25. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY INDIVIDUAL, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 26. AMERICAS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 27. ARGENTINA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 28. BRAZIL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 29. CANADA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 30. MEXICO EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 31. UNITED STATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 32. ASIA-PACIFIC EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 33. AUSTRALIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 34. CHINA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 35. INDIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 36. INDONESIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 37. JAPAN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 38. MALAYSIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 39. PHILIPPINES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 40. SINGAPORE EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 41. SOUTH KOREA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 42. THAILAND EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 43. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 44. FRANCE EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 45. GERMANY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 46. ITALY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 47. NETHERLANDS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 48. QATAR EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 49. RUSSIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 50. SAUDI ARABIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 51. SOUTH AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 52. SPAIN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 53. UNITED ARAB EMIRATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 54. UNITED KINGDOM EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 55. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET: FPNV POSITIONING MATRIX
  • FIGURE 56. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET: SHARE, BY KEY PLAYER, 2020
  • FIGURE 57. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 4. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY DOSAGE, 2018-2026 (USD MILLION)
  • TABLE 5. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY 0.3 MG EPINEPHRINE AUTOINJECTOR, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 6. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY 0.5 MG EPINEPHRINE AUTOINJECTOR, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 7. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY MG EPINEPHRINE AUTOINJECTOR, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 8. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY END-USER, 2018-2026 (USD MILLION)
  • TABLE 9. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY CLINICS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 10. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 11. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, BY INDIVIDUAL, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 12. AMERICAS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 13. ARGENTINA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 14. BRAZIL EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 15. CANADA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 16. MEXICO EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 17. UNITED STATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 18. ASIA-PACIFIC EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 19. AUSTRALIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 20. CHINA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 21. INDIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 22. INDONESIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 23. JAPAN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 24. MALAYSIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 25. PHILIPPINES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 26. SINGAPORE EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 27. SOUTH KOREA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 28. THAILAND EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 29. EUROPE, MIDDLE EAST & AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 30. FRANCE EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 31. GERMANY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 32. ITALY EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 33. NETHERLANDS EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 34. QATAR EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 35. RUSSIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 36. SAUDI ARABIA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 37. SOUTH AFRICA EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 38. SPAIN EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 39. UNITED ARAB EMIRATES EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 40. UNITED KINGDOM EPINEPHRINE AUTO-INJECTOR MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 41. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET: SCORES
  • TABLE 42. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET: BUSINESS STRATEGY
  • TABLE 43. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET: PRODUCT SATISFACTION
  • TABLE 44. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET: RANKING
  • TABLE 45. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET: SHARE, BY KEY PLAYER, 2020
  • TABLE 46. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET: MERGER & ACQUISITION
  • TABLE 47. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 48. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 49. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET: INVESTMENT & FUNDING
  • TABLE 50. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 51. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET: LICENSE & PRICING
目次
Product Code: MRR-4348D129FAC9

The Global Epinephrine Auto-Injector Market size was estimated at USD 268.02 Million in 2020 and expected to reach USD 292.68 Million in 2021, at a Compound Annual Growth Rate (CAGR) 9.53% to reach USD 462.98 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Epinephrine Auto-Injector to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Dosage, the Epinephrine Auto-Injector Market was studied across 0.3 Mg Epinephrine Autoinjector, 0.5 Mg Epinephrine Autoinjector, and Mg Epinephrine Autoinjector.
  • Based on End-User, the Epinephrine Auto-Injector Market was studied across Clinics, Hospital, and Individual.
  • Based on Region, the Epinephrine Auto-Injector Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Epinephrine Auto-Injector Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Epinephrine Auto-Injector Market, including ALK-Abello A/S, Amedra Pharmaceuticals LLC, Amgen Inc., Amneal Pharmaceuticals Inc., Antares Pharma Inc., Bausch Health Companies, Inc., Bayer AG, Becton, Dickinson and Company, BPI Labs, Inc., Eli Lilly and Company, GlaxoSmithKline PLC, Hospice Inc, Hospira Inc., Impax Laboratories, Inc., Janssen Global Services, LLC, Kaleo, Inc., Lincoln Medical Centre Ltd., Lincoln Medical Ltd, Merck KGaA, Mylan Inc, Novartis International AG, Pfizer, Inc., Sanofi SA, Teva Pharmaceuticals Lts, and Ypsomed Holding.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Epinephrine Auto-Injector Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Epinephrine Auto-Injector Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Epinephrine Auto-Injector Market?
  • 4. What is the competitive strategic window for opportunities in the Global Epinephrine Auto-Injector Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Epinephrine Auto-Injector Market?
  • 6. What is the market share of the leading vendors in the Global Epinephrine Auto-Injector Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Epinephrine Auto-Injector Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Dosage Outlook
  • 3.4. End-User Outlook
  • 3.5. Region Outlook
  • 3.6. Competitor Outlook

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cumulative Impact of COVID-19

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing awareness about allergies
      • 5.1.1.2. Technological developments in research & development activities
      • 5.1.1.3. High demand for autoinjectors instead of conventional devices such as standard syringes
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of epinephrine auto injector
    • 5.1.3. Opportunities
      • 5.1.3.1. Demand for easy usability of disposable drug injectors
      • 5.1.3.2. Increase in the demand for self-management of anaphylaxis
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations imposed by the government
  • 5.2. Porters Five Forces Analysis
    • 5.2.1. Threat of New Entrants
    • 5.2.2. Threat of Substitutes
    • 5.2.3. Bargaining Power of Customers
    • 5.2.4. Bargaining Power of Suppliers
    • 5.2.5. Industry Rivalry

6. Epinephrine Auto-Injector Market, by Dosage

  • 6.1. Introduction
  • 6.2. 0.3 Mg Epinephrine Autoinjector
  • 6.3. 0.5 Mg Epinephrine Autoinjector
  • 6.4. Mg Epinephrine Autoinjector

7. Epinephrine Auto-Injector Market, by End-User

  • 7.1. Introduction
  • 7.2. Clinics
  • 7.3. Hospital
  • 7.4. Individual

8. Americas Epinephrine Auto-Injector Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Epinephrine Auto-Injector Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Thailand

10. Europe, Middle East & Africa Epinephrine Auto-Injector Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Key Player
  • 11.4. Competitive Scenario
    • 11.4.1. Merger & Acquisition
    • 11.4.2. Agreement, Collaboration, & Partnership
    • 11.4.3. New Product Launch & Enhancement
    • 11.4.4. Investment & Funding
    • 11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. ALK-Abello A/S
  • 12.2. Amedra Pharmaceuticals LLC
  • 12.3. Amgen Inc.
  • 12.4. Amneal Pharmaceuticals Inc.
  • 12.5. Antares Pharma Inc.
  • 12.6. Bausch Health Companies, Inc.
  • 12.7. Bayer AG
  • 12.8. Becton, Dickinson and Company
  • 12.9. BPI Labs, Inc.
  • 12.10. Eli Lilly and Company
  • 12.11. GlaxoSmithKline PLC
  • 12.12. Hospice Inc
  • 12.13. Hospira Inc.
  • 12.14. Impax Laboratories, Inc.
  • 12.15. Janssen Global Services, LLC
  • 12.16. Kaleo, Inc.
  • 12.17. Lincoln Medical Centre Ltd.
  • 12.18. Lincoln Medical Ltd
  • 12.19. Merck KGaA
  • 12.20. Mylan Inc
  • 12.21. Novartis International AG
  • 12.22. Pfizer, Inc.
  • 12.23. Sanofi SA
  • 12.24. Teva Pharmaceuticals Lts
  • 12.25. Ypsomed Holding

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing